All News

A look at unintentional causes of injury death in the United States and medication safety.

Eliminating retroactive pharmacy payment reductions — or post point-of-sale pharmacy "DIR fees" — in Medicare Part D would save the federal government $3.4 billion over 10 years, according to a Wakely Consulting Group study released today by the National Community Pharmacists Association.

Abemaciclib treats adults with hormone receptor-positive, human epidemical growth factor receptor-negative advanced or metastatic breast cancer that progressed after endocrine therapy.

Verzenio can be administered as a stand-alone treatment to patients previously treated with endocrine therapy and chemotherapy.

Officials with the FDA have approved abemaciclib (Verzenio, Eli Lilly), for the treatment of adults with certain advanced or metastatic breast cancer.

The agreement requires Amgen to pay royalties to AbbVie for sales of the biosimilar, according to a press release.

Reports from an investment bank suggest Amazon is looking to collaborate with a PBM.

CVS to limit opioid prescriptions to 7 days for certain conditions.

Higher-income individuals living in low-income areas had lower cardiovascular risks than those with lower incomes.

Promotion of healthy lifestyle changes are crucial among HIV-positive patients cured of hepatitis C.

Top news of the day from across the health care landscape.

Agreement clears path to launch of Humira biosimilar.

AbbVie grants commercialization rights to Amjevita.

Top news of the day from across the healthcare landscape.

The award goes to the organization that has done the most to advance patient care and the practice of specialty pharmacy.

New classes of multiple sclerosis medications are improving on disease suppression.

System involves a small sensor wire inserted below the skin’s surface to continuously measure and monitor glucose in adults with diabetes.

Officials with the FDA have approved FreeStyle Libre Flash Glucose Monitoring System (Abbot Diabetes Care Inc.), the first continuous glucose monitoring system for adult patients that reduces the need for fingerstick testing.

Capturing the correct patient data can enhance current specialty pharmacy programs to drive unparalleled care.

Taking massive doses of vitamin C to protect against viruses and diseases may actually have harmful effects.

High costs of prescription drugs outweigh the concern of quality of care received in some states.

Mice treated prophylactically were protected from developing multiple sclerosis and neurological deficits.

Top news of the day from across the health care landscape.

BAX 930 mimics a key clotting enzyme, and could one day eliminate the need for plasma infusions for hereditary thrombotic thrombocytopenic purpura.

Tobacco control policies decreased hospitalization for severe chest infections in children by 18%.

Exercise and a high-protein, low-glycemic diet could improve asthma symptoms by 50%.

Top news of the day from across the healthcare landscape.

Coffee drinking can cut down risk of all-cause mortality in patients with HIV and hepatitis C virus (HCV) by half, according to a 5-year study published in the Journal of Hepatology.

Janssen submits new drug application for darunavir-based, once-daily, single-tablet regimen for the treatment of HIV in adults and adolescents who are 12 years of age or older.

Concerns persist that excess folic acid supplementation may cause asthma in young children.